The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Study critique · continued

A claim built entirely on a subgroup analysis posts 61–81

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

JR
j.rasmussenTL2Regular28 May 2025#61

Practical answer on claim built, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated explanation is needed. It usually is not.

8 likes 14mo
IB
i.balogunTL229 May 2025#62

A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.

2 likes 14mo
LC
l.chevalierTL3Regular29 May 2025#63
Nicolaides, post #34: Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters. Correct me on the arithmetic if it is wrong; I would rather know. Go to post

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

I have left out the parts I could not verify.

0 likes in reply to #34 14mo
YA
y.adeyemiTL230 May 2025#64
n.haddad, post #20: Good question, well framed, and I would like to see it answered properly. Go to post

Post #61 is right about the mechanism and I think understates the practical bit.

Genuine question rather than a rhetorical one: has anyone here actually observed claim built, as opposed to read about it? The thread is long and I cannot tell.

26 likes in reply to #20 14mo
B
batchlogTL3Regular30 May 2025 · edited#65

A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper.

12 likes 14mo
DF
d.ferreiraTL231 May 2025#66

Appreciated. The plain phrasing does more work here than a longer post would.

4 likes 14mo
TY
two_year_lineTL3Regular31 May 2025#67

I read post #65 twice before replying, because I had assumed the opposite.

The version of claim built that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those conditions are where the interesting cases live.

0 likes 14mo
CC
c.chowdhuryTL21 Jun 2025#68
a.reyes, post #28: This follows post #25 rather than contradicting it. Worth separating claim built as a question about the compound from claim built as a question about the documentation. They get answered by different people and only one of them is answerable here. Go to post

Post #65 answers the question as asked. The question underneath it is different.

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

I am confident about the direction and much less about the magnitude.

0 likes in reply to #28 14mo
CN
c.niemelTL3Regular1 Jun 2025#69
t.ndiaye, post #21: Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you nothing about the person asking. That is my reading. Someone else read the same page differently and was reasonable. Go to post

Checked the claim built claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.

18 likes in reply to #21 14mo
ND
n.dziedzicTL22 Jun 2025#70

Building on post #69 rather than restating it.

The honest answer on claim built is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.

Most people get the first two right and then argue about the fourth.

7 likes 14mo
KR
k.radichTL22 Jun 2025#71

Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you nothing about the person asking.

13 likes 14mo
BO
b.oseiTL23 Jun 2025#72
cannula_drift, post #32: Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of no practical consequence. Go to post

Reframing claim built slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often", nobody here knows.

28 likes in reply to #32 14mo
BS
b.solbergTL23 Jun 2025#73

Adding a note of thanks rather than an opinion. I did not know most of that.

0 likes 14mo
HM
h.mbekiTL24 Jun 2025 · edited#74

I had written a reply contradicting post #70 and deleted it. Here is what survived.

I have three months of notes on claim built and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion from the first fortnight.

2 likes 14mo
SL
s.leclercTL4 Moderator4 Jun 2025#75

Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by default. Reporting both is the practice worth insisting on.

19 likes 14mo
NS
n.silvaTL25 Jun 2025#76
j.steiner, post #25: Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated for this use. Go to post

Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of no practical consequence.

0 likes in reply to #25 14mo
AR
a.reyesTL4 Admin5 Jun 2025#77

Adding what did not work for me on claim built, since the failures never get written up and they are half the useful information.

0 likes 14mo
LS
l.salinasTL26 Jun 2025#78

Coming back to post #74, because the follow-up matters more than the original answer.

Where a critique rests on a subgroup, check whether the interaction was tested. A difference between subgroups that is not statistically supported is not a difference.

That holds for the case as described. Change the assumptions and it may not.

5 likes 14mo
ST
stopper_traceTL2Member6 Jun 2025#79
w.verhoeven, post #33: What I can speak to on claim built is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know. Go to post

This follows post #76 rather than contradicting it.

Placebo-controlled versus active-controlled changes what a result means entirely, and comparing across the two is one of the most common errors in this subcategory.

On reflection I would soften that slightly.

27 likes in reply to #33 14mo
NH
n.hartmannTL26 Jun 2025#80

No notes. Posting so the count is not one.

0 likes 14mo
YI
y.ibarraTL27 Jun 2025#81
a.reyes, post #28: This follows post #25 rather than contradicting it. Worth separating claim built as a question about the compound from claim built as a question about the documentation. They get answered by different people and only one of them is answerable here. Go to post

Adding thanks rather than a view. I do not have a view worth the space.

16 likes in reply to #28 14mo

Suggested topics

TopicParticipantsRepliesViewsActivity
About the Study critique category
Structured criticism of a specific published study. Criticise the method, not the author. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
BNJNDEHF 4 114 16mo
Measurement error in a self-reported exposure
Posting this under the heading it deserves: Measurement error in a self-reported exposure Everything below is what sits behind that. The question about measurement error that I actually want answered is the…
LHCKSVCW+117 129 45k 5mo
Selection into a registry and what it does to the estimate
Selection into a registry and what it does to the estimate — setting out what I have, and where I think it stops being reliable. Working notes on selection rather than a conclusion. I would rather post the…
SSLMAA 2 55k 7mo
Coming back to: A structured critique template this community uses
Posting this under the heading it deserves: A structured critique template this community uses Everything below is what sits behind that. Reading back through what has been written here about structured…
SOFAKHASMY+63 69 17k 18h
A claim built entirely on a subgroup analysis — what changed since
On the subject in the title: A claim built entirely on a subgroup analysis — what changed since Working notes rather than a conclusion. What changes if the standard account of claim built is wrong? I ask…
AWZCQZ 2 2k 18mo

Related topics — sharing the tags risk of bias, observational data, confounding

TopicParticipantsRepliesViewsActivity
Reading a rodent study on a secretagogue without over-extrapolating — the long version
Reading a rodent study on a secretagogue without over-extrapolating — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about Reading a rodent study,…
CDDBANKBMA+59 66 30k 4h
Criticising the method without criticising the authors
Criticising the method without criticising the authors Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about criticising the method without criticising in a…
KBZOKOJMTV+55 61 60k 15mo
Pooling trials with different estimands
On the subject in the title: Pooling trials with different estimands Working notes rather than a conclusion. Asking about pooling trials with different estimands on behalf of the question I keep seeing asked…
RCFCTSRMME+120 132 2.3k 1d
One lot is one lot: when a report becomes a pattern
Posting this under the heading it deserves: One lot is one lot: when a report becomes a pattern Everything below is what sits behind that. Structured report rather than an opinion, following the format the…
NCCRM 2 19k 14mo
Tracking a preprint to publication: a worked example — the long version
Posting this under the heading it deserves: Tracking a preprint to publication: a worked example — the long version Everything below is what sits behind that. A preprint question rather than a question about…
PBHJEFAKGC+38 47 560 22mo